Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A 6-month, Multi-centre, Open Labelled, Non-randomized, Non-interventional, Safety Study of Liraglutide (Victoza®) in Subjects With Type 2 Diabetes Mellitus in Korea

NCT01821846 is registered in ClinicalTrials.gov with Novo Nordisk A/S as lead sponsor.

NCT NCT01821846
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01821846 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A 6-month, Multi-centre, Open Labelled, Non-randomized, Non-interventional, Safety Study of Liraglutide (Victoza®) in Subjects With Type 2 Diabetes Mellitus in Korea
Lead sponsor
Novo Nordisk A/S
Phase
Observational
Overall status
Completed
Start date
November 20, 2013
Completion date
March 8, 2017
Enrollment
64 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes, diabetes mellitus, type 2